Oncology

Latest News

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

By AJMC Contributor

April 23rd 2025

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a case study in small cell lung cancer (SCLC) illustrates.

Diabetes monitoring | Image credit: abidika - stock.adobe.com

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

By Pearl Steinzor

April 23rd 2025

Vitamin D | Image credit: Galina Zhigalova - stock.adobe.com

Vitamin D’s Potential Role in Colorectal Cancer Prevention, Immune Health

By Pearl Steinzor

April 23rd 2025

The study highlighted symptom patterns in the short-term preceding ED visits and unplanned hospitalizations using a previously validated natural language processing a pipeline. | Image credit: Tyler Olson - stock.adobe.com

Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities

By Rose McNulty

April 22nd 2025

Patient navigation | Image credit: AON

With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

By Mary Caffrey

April 22nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Linda House Highlights the Effect of Strong Patient-Physician Relationships

March 14th 2015

Linda House Highlights the Effect of Strong Patient-Physician Relationships

Patient-provider dialogue before making treatment decisions affects how satisfied patients are with their overall care, Linda House, RN, BSN, MSM, president of the Cancer Support Community, said at the National Comprehensive Cancer Network 20th Annual Conference.

NCCN Guidelines Become Resource Stratified for Global Use

March 13th 2015

NCCN Guidelines Become Resource Stratified for Global Use

Laura Joszt, MA

Resource constraints may confine the ability of physicians to deliver optimal cancer care to all patients across the world, which the National Comprehensive Cancer Network is acknowledging by resource stratifying its Guidelines.

Dr Peter Bach Explains Diminishing Returns in Cancer Drugs

March 13th 2015

Dr Peter Bach Explains Diminishing Returns in Cancer Drugs

While the cost of introductory cancer drugs is increasing rapidly, there has not been a commensurate increase in benefit, according to Peter Bach, MD, with Memorial Sloan Kettering Cancer Center.

March 13th 2015

NCCN Recommends Only One Test for Breast Cancer, Says Expert

According to Dr Amy Cyr from the Siteman Cancer Center at Washington University in St. Louis, Missouri, while Oncotype DX is both prognostic and predictive, none of the other tests currently available have shown both capabilities.

March 13th 2015

Low Breast Density Could Indicate Poor Prognosis, Study Suggests

The findings of this study, conducted in Finland, may prove significant for the assessment of breast cancer prognosis and treatment planning.

March 13th 2015

CDC Report Underscores Impact of Early Diagnosis and Innovation on Cancer Survival

Two out of three people with metastatic disease survive 5 years or more, the report shows. The authors hope the data can help researchers develop better cancer control programs.

20 Years of Creating and Embracing Guidelines in Cancer Care

March 13th 2015

20 Years of Creating and Embracing Guidelines in Cancer Care

Laura Joszt, MA

When the first National Comprehensive Cancer Network Guidelines were developed 20 years ago, even the participating members who were there at the beginning were skeptical they would be able to come to an agreement and build something lasting.

March 13th 2015

Geography Determines Appropriate Use of Imaging in Low-Risk Cancer Patients

The study, published in JAMA Oncology, found that low risk breast and prostate cancer patients received unnecessary imaging overall, with a higher rate observed in the North East region of the country.

March 12th 2015

ACS Study Recommends Increased Screening to Reduce Incidence of Colorectal Cancer

The study, published in the journal Cancer found that increasing screening rates to 80% by 2018 would reduce projected colorectal cancer incidence rates by 17% and mortality rates by 19% during short-term follow-up, and by 22% and 33%, respectively, during extended follow-up. Those reductions would amount to a total of 277,000 averted new cancers and 203,000 averted colorectal cancer deaths from 2013 through 2030.

Dr Robert Carlson Highlights Top NCCN Meeting Takeaway

March 12th 2015

Dr Robert Carlson Highlights Top NCCN Meeting Takeaway

The National Comprehensive Cancer Network (NCCN) Guidelines may be successful historically, but the network isn't resting on its laurels, Robert Carlson, MD, chief executive officer, said at the NCCN 20th Annual Meeting.

Transforming the NCCN Guidelines

March 12th 2015

Transforming the NCCN Guidelines

Laura Joszt, MA

During his keynote speech at the National Comprehensive Cancer Network (NCCN)'s 20th Annual Conference, Chief Executive Officer Robert Carlson, MD, spent the majority of his time discussing the NCCN Guidelines because they are the core of its services.

March 12th 2015

A New Strategy for Payers to Cover High Cost Specialty Medications?

A new analysis published by the RAND Corporation suggests strategies that the pharmaceutical industry could offer payers as they try to cover the front-loaded cost of newer breakthrough drugs.

March 12th 2015

Dietary Restrictions Could Prevent Colon Cancer

The study, published in JAMA Internal Medicine, found that while the complete absence of meat in the diet had the most impact on reducing the risk of colorectal cancer, those who added seafood to the vegetarian diet-pescovegetarians-faired better than the nonvegetarians.

March 12th 2015

Study Shows Experienced Care Facilities Improve Survival in NSCLC

The study, published in the Journal of Thoracic Oncology, found that patients treated with definitive concurrent chemotherapy and radiation therapy for stage 3 non-small cell lung cancer have longer overall survival when treated by highly experienced facilities, either academic or community cancer centers.

March 11th 2015

Myriad's Gene Panel Could Diagnose Metastatic Melanoma

The 23-gene diagnostic panel called myPath Melanoma could be used in addition to microscopy to distinguish the benign form of the disease from malignant disease.

March 11th 2015

Scientist Whose Discoveries Helped Develop Ipilimumab Among ASCO Honorees

The awards will be presented at ASCO's annual meeting to be held in Chicago in May this year.

March 11th 2015

NICE Recommends Gazyvaro for Treatment-Naive CLL Patients

The recommendation has not come easy for Roche. Back in October 2014, NICE had rejected Gazyravo based on inconsistencies in the filing, which were then addressed by the drug manufacturer. Subsequently, NICE struck a deal with Roche to provide the drug to NHS at a reduced price.

March 10th 2015

Escalating Drug Prices Not a Concern for All

While the PBM Express Scripts declared plans to bring cancer drug plans down, the drug manufacturers and investors aren't too worried about the high cost of some of the specialty drugs, according to this article in Bloomberg.

March 10th 2015

Breast Cancer Survivors Have Increased Risk of Thyroid Cancer

Laura Joszt, MA

Within 5 years of a breast cancer diagnosis, patients are at an increased risk of developing thyroid cancer, according to a new study, which was presented at the Endocrine Society's 97th annual meeting.

March 10th 2015

Study Evaluates Benefits of Cap on Prescription Drug Cost-Sharing for Patients on Exchanges

Commissioned by The Leukemia and Lymphoma Society, the results of the study help make the case for placing limits on out-of-pocket costs for patients that would relieve their financial burden without a significant impact to insurers.

March 9th 2015

Turning That Cell Phone Into a Tool for Oncology Care

Mary K. Caffrey

March 9th 2015

As Use of Diagnostics Rises, Challenges Remain in Education, Reimbursement

Mary K. Caffrey

March 9th 2015

Surveys Find Agreement in What Stakeholders Want From Cancer Care, and Oncology Medical Homes Deliver

March 9th 2015

How the ACA Is Changing Oncology Practice on the Ground

Mary K. Caffrey

March 9th 2015

Payers Seek Quality Measures That Matter to Patients, Fox Says

Mary K. Caffrey

March 9th 2015

Cost Matters to Cancer Patients, and Care Costs More in Hospitals, Panel Agrees

Mary K. Caffrey

March 9th 2015

As Cancer Becomes a Chronic Condition, Payers Shift Focus to Survivorship

March 9th 2015

ASCO's Yu Outlines How the "Changing Value Proposition" Is Redefining the Oncologist's Role

Mary K. Caffrey

March 9th 2015

Prostate Cancer in the Family Tree Increases A Woman's Risk of Breast Cancer

A study, published in the journal Cancer, found that women with a family history of both breast and prostate cancer among first-degree relatives have an almost 2-fold increase in risk of developing breast cancer themselves.

March 9th 2015

ASCO and PhRMA Critical of the CMS Oncology Care Model

One of the criticisms, which came from ASCO, points to the absence of consideration for patient heterogeneity that can result in physicians being penalized for providing patient-centered treatment.

...

134 135 136 137 138 139 140 141 142

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions